“What used to take us 2 years just took 2 months, soup to nuts with Varigen’s technology — we will be moving to publish this now-deorphaned Natural Product straight away!”

— Neil Kelleher, Northwestern University, ACS Chemical Biology, 2020

In the News

March

2020

Varigen Biosciences selected to present its genome mining technologies for agricultural applications at the World Agri-Tech Innovation Summit in San Francisco, March 17-18, 2020. 

June

2019

Varigen Biosciences presents “New Tools for Targeted Cloning and Over Expression of Biosynthetic Gene Clusters” at the 2nd Synthetic Biology For Natural Products Conference.

May

2019

Varigen Biosciences will present “New Tools for Targeted Cloning and Over Expression of Biosynthetic Gene Clusters” at the Copenhagen Bioscience Conference 16 – Natural Products: Discovery, Biosynthesis and Application.

September

2018

Varigen Biosciences will give a talk entitled “Gel Free Targeted Cloning of Large Biosynthetic Gene Clusters” at the 3rd European Conference on Natural Products.

August

2018

Varigen Biosciences will give a talk entitled “Mining and Expressing Biosynthetic Gene Clusters from Soil Metagenomes,” at the SIMB Annual Meeting 2018.

July

2018

Varigen Biosciences is awarded a National Institutes of Health SBIR Phase I grant to enable capture of intact, long DNA from complex samples.

July

2017

Varigen Biosciences certified by State of Wisconsin as a Qualified New Business Venture.

May

2017

Varigen Biosciences is awarded a National Institutes of Health SBIR grant to enable cloning of complex and large DNAs, such as biosynthetic gene clusters.

March

2017

Dr. David Mead, CEO of Varigen Biosciences, co-organizes Synthetic Biology for Natural Products meeting.

January

2017

Varigen Biosciences is awarded a National Science Foundation SBIR grant to enable amplification of biosynthetic gene clusters and other large DNAs.

Varigen™ Biosciences

Natural Products by Design™